Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
-
Publication Venue For
-
Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium..
27:1186-1194.
2018
-
Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk..
27:1151-1158.
2018
-
Validation of a blood biomarker for identification of individuals at high risk for gastric cancer.
2018
-
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)..
27:438-445.
2018
-
Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China..
27:342-344.
2018
-
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium..
27:174-182.
2018
-
Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors..
27:67-74.
2018
-
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium..
26:1470-1473.
2017
-
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.
2017
-
Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer-Response..
26:977.
2017
-
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival..
26:420-424.
2017
-
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci..
26:116-125.
2017
-
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers..
26:126-135.
2017
-
Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES)..
25:1411-1417.
2016
-
Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer..
25:1418-1425.
2016
-
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium..
25:1114-1124.
2016
-
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions..
25:1037-1042.
2016
-
Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia..
25:1043-1049.
2016
-
Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer..
25:766-772.
2016
-
Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors..
25:780-790.
2016
-
What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic Factors..
25:613-623.
2016
-
Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer..
25:446-454.
2016
-
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium..
25:470-478.
2016
-
Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database..
25:547-554.
2016
-
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study..
25:282-290.
2016
-
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer..
25:193-200.
2016
-
Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study..
24:1699-1706.
2015
-
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk..
24:1574-1584.
2015
-
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies..
24:1366-1372.
2015
-
Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma..
24:1101-1110.
2015
-
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci..
24:1121-1129.
2015
-
Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy..
24:913-920.
2015
-
Population distribution of lifetime risk of ovarian cancer in the United States..
24:671-676.
2015
-
Survivors of childhood cancer in the United States: prevalence and burden of morbidity..
24:653-663.
2015
-
Symptoms, weight loss and physical function in a lifestyle intervention study of older cancer survivors..
24:763-764.
2015
-
Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease..
24:435-441.
2015
-
Efficacy of a couple-based randomized controlled trial to help Latino fathers quit smoking during pregnancy and postpartum: the Parejas trial..
24:379-385.
2015
-
Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study..
23:2936-2942.
2014
-
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II..
23:2561-2567.
2014
-
Abstract A30: Using the principles of community-based participatory research to build an office of health equity within a nationally designated cancer institute.
23:A30-A30.
2014
-
Abstract B22: Altered methylation profiles of imprinted genes in response to prenatal exposure to cigarette smoke in the Newborn Epigenetic STudy (NEST) cohort.
23:B22-B22.
2014
-
Abstract C16: Feasibility study: Protein profiling of primary breast cancers from premenopausal women.
23:C16-C16.
2014
-
Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report..
23:2613-2617.
2014
-
Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer..
23:2503-2511.
2014
-
Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy..
23:2404-2412.
2014
-
Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database..
23:2349-2356.
2014
-
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer..
23:2328-2337.
2014
-
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease..
23:1997-2008.
2014
-
A review of the application of inflammatory biomarkers in epidemiologic cancer research..
23:1729-1751.
2014
-
Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial..
23:1944-1947.
2014
-
Decline in physical activity level in the Childhood Cancer Survivor Study cohort..
23:1619-1627.
2014
-
A prospective study of plasma Selenoprotein P and lung cancer risk among low-income adults..
23:1238-1244.
2014
-
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer..
23:1421-1427.
2014
-
Oral contraceptive use and risk of cancer--response..
23:677-678.
2014
-
Helicobacter pylori Biomarkers and Risk of Colorectal Oncogenesis--Response..
23:366.
2014
-
Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases..
23:274-281.
2014
-
Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium..
23:160-171.
2014
-
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer..
22:1964-1974.
2013
-
Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review..
22:1931-1943.
2013
-
Age-specific occurrence of HPV16- and HPV18-related cervical cancer..
22:1313-1318.
2013
-
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome..
22:987-992.
2013
-
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer..
22:880-890.
2013
-
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression..
22:827-834.
2013
-
Transforming Epidemiology for 21st Century Medicine and Public Health.
22:508-516.
2013
-
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes..
22:461-466.
2013
-
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans..
22:251-260.
2013
-
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma..
21:2242-2251.
2012
-
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men..
21:2185-2192.
2012
-
Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey..
21:2108-2117.
2012
-
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.
21:1655-1663.
2012
-
Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma..
21:1336-1343.
2012
-
Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study..
21:1078-1088.
2012
-
Cigarette smoking and risk of meningioma: the effect of gender..
21:943-950.
2012
-
Common variation in Nemo-like kinase is associated with risk of ovarian cancer..
21:523-528.
2012
-
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes..
21:529-536.
2012
-
No association between Parkinson disease alleles and the risk of melanoma..
21:243-245.
2012
-
Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck..
20:2642-2645.
2011
-
Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer..
20:2438-2449.
2011
-
Methods to assess adverse health-related outcomes in cancer survivors..
20:2022-2034.
2011
-
Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers..
20:1912-1917.
2011
-
Assessment of hepatocyte growth factor in ovarian cancer mortality..
20:1638-1648.
2011
-
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium..
20:1793-1797.
2011
-
Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased..
20:1543-1551.
2011
-
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1..
20:1078-1088.
2011
-
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk..
20:1131-1145.
2011
-
Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer..
20:779-792.
2011
-
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer..
20:1028-1031.
2011
-
Race, African ancestry, and Helicobacter pylori infection in a low-income United States population..
20:826-834.
2011
-
A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers..
20:658-664.
2011
-
Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data..
20:476-482.
2011
-
Assessment of type of allergy and antihistamine use in the development of glioma..
20:370-378.
2011
-
Validation of genome-wide prostate cancer associations in men of African descent..
20:23-32.
2011
-
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium..
19:1822-1830.
2010
-
FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck..
19:1484-1491.
2010
-
Urinary biomarkers of oxidative status in a clinical model of oxidative assault..
19:1506-1510.
2010
-
Genetic susceptibility variants for chronic lymphocytic leukemia..
19:1098-1102.
2010
-
Longitudinal predictors of nonadherence to maintenance of mammography..
19:1103-1111.
2010
-
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium..
19:600-604.
2010
-
Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study..
19:170-181.
2010
-
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study..
19:245-250.
2010
-
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group..
18:3133-3137.
2009
-
Sexually transmitted infections and prostate cancer among men in the U.S. military..
18:2665-2671.
2009
-
Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study..
18:1962-1970.
2009
-
Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study..
18:1953-1961.
2009
-
Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans..
18:1552-1561.
2009
-
Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium..
18:1544-1551.
2009
-
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study..
18:1379-1385.
2009
-
Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls..
18:1232-1238.
2009
-
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk..
18:935-944.
2009
-
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..
18:541-550.
2009
-
Race/ethnicity, physical activity, and quality of life in breast cancer survivors..
18:656-663.
2009
-
Association and interactions between DNA repair gene polymorphisms and adult glioma..
18:204-214.
2009
-
Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer..
18:28-34.
2009
-
Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study..
18:314-320.
2009
-
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer..
17:3467-3473.
2008
-
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery..
17:3577-3587.
2008
-
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women..
17:3567-3572.
2008
-
Comparing the reliability of responses to telephone-administered versus self-administered Web-based surveys in a case-control study of adult malignant brain cancer..
17:2639-2646.
2008
-
Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique..
17:2350-2355.
2008
-
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention..
17:1884-1890.
2008
-
Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..
17:1974-1981.
2008
-
Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis..
17:1822-1831.
2008
-
Performance of amplified DNA in an Illumina GoldenGate BeadArray assay..
17:1781-1789.
2008
-
The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis..
17:1739-1745.
2008
-
DNA repair capacity and lung cancer risk in never smokers..
17:1322-1328.
2008
-
Differences in baseline characteristics and outcomes at 1- and 2-year follow-up of cancer survivors accrued via self-referral versus cancer registry in the FRESH START Diet and exercise trial..
17:1288-1294.
2008
-
Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans..
17:768-776.
2008
-
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup..
17:585-593.
2008
-
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium..
17:484-489.
2008
-
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer..
17:397-404.
2008
-
Cyclin E overexpression relates to ovarian cancer histology but not to risk factors [2].
17:1841-1842.
2008
-
Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk..
16:2756-2762.
2007
-
Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer..
16:2379-2386.
2007
-
GLIOGENE an International Consortium to Understand Familial Glioma..
16:1730-1734.
2007
-
Oral contraceptives and survival in breast cancer patients aged 20 to 54 years..
16:1822-1827.
2007
-
Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck..
16:1633-1638.
2007
-
Common variation in the BRCA1 gene and prostate cancer risk..
16:1510-1516.
2007
-
Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study..
16:1356-1363.
2007
-
Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans..
16:1294-1297.
2007
-
Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention..
16:1032-1034.
2007
-
Dietary mutagen exposure and risk of pancreatic cancer..
16:655-661.
2007
-
Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology..
16:613-616.
2007
-
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer..
16:473-480.
2007
-
In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry..
16:223-227.
2007
-
Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.
16:2587-2593.
2007
-
Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk..
16:50-56.
2007
-
Pooling of case specimens to create standard serum sets for screening cancer biomarkers.
16:334-341.
2007
-
Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites..
15:2364-2369.
2006
-
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis..
15:2526-2532.
2006
-
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2..
15:2311-2313.
2006
-
Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers..
15:1703-1707.
2006
-
Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population..
15:1336-1340.
2006
-
Barriers to full colon evaluation for a positive fecal occult blood test..
15:1232-1235.
2006
-
DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset..
15:886-891.
2006
-
Mathematical modeling: epidemiology meets systems biology..
15:827-829.
2006
-
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer..
15:935-938.
2006
-
APC I1307K and the risk of prostate cancer..
15:468-473.
2006
-
Combined effects of the p53 and p73 polymorphisms on lung cancer risk..
15:158-161.
2006
-
Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women..
14:3013-3014.
2005
-
Interest in testing for genetic susceptibility to lung cancer among Black college students "at risk" of becoming cigarette smokers..
14:2978-2981.
2005
-
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer..
14:2536-2543.
2005
-
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort..
14:2413-2418.
2005
-
Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck..
14:1961-1966.
2005
-
Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta..
14:2035-2039.
2005
-
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori..
14:1883-1889.
2005
-
XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies..
14:1810-1818.
2005
-
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer..
14:1470-1476.
2005
-
Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer..
14:1453-1459.
2005
-
Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms..
14:1477-1484.
2005
-
Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis..
14:1188-1193.
2005
-
Response rates to a mailed survey targeting childhood cancer survivors: a comparison of conditional versus unconditional incentives..
14:1330-1332.
2005
-
CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck..
14:1034-1036.
2005
-
Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk..
14:821-825.
2005
-
Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration..
14:790-798.
2005
-
Safety and efficacy of weekly oral oltipraz in chronic smokers..
14:892-899.
2005
-
The biology of tobacco and nicotine: bench to bedside..
14:764-767.
2005
-
IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men..
14:403-408.
2005
-
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers..
13:2141-2147.
2004
-
Racial differences in enrolment in a cancer genetics registry..
13:1349-1354.
2004
-
No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck..
13:1081-1083.
2004
-
Modifying attributions of colorectal cancer risk..
13:560-566.
2004
-
High-throughput detection of glutathione s-transferase polymorphic alleles in a pediatric cancer population..
13:304-313.
2004
-
Association between low dietary folate intake and suboptimal cellular DNA repair capacity..
12:963-969.
2003
-
Dietary folate intake and lung cancer risk in former smokers: a case-control analysis..
12:980-986.
2003
-
Genetic susceptibility to lung cancer: the role of DNA damage and repair..
12:689-698.
2003
-
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina..
12:226-227.
2003
-
Correspondence re: Zheng et al, Haplotype of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. 11: 640-645, 2002..
12:71.
2003
-
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma..
11:1142-1143.
2002
-
Environmental factors in relation to breast cancer characterized by p53 protein expression..
11:829-835.
2002
-
Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study..
11:640-645.
2002
-
Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income..
11:521-528.
2002
-
Communicating breast cancer risks to women using different formats..
10:895-898.
2001
-
Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000..
10:415-416.
2001
-
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study..
10:397-401.
2001
-
Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx..
10:273-275.
2001
-
Relationships among breast cancer perceived absolute risk, comparative risk, and worries..
9:973-975.
2000
-
The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer..
9:439-442.
2000
-
Early onset baldness and prostate cancer risk..
9:325-328.
2000
-
Increased weight & body fatness associated with chemotherapy for breast cancer ... & what can be done?.
9:236-236.
2000
-
Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction..
8:801-807.
1999
-
Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer..
8:533-539.
1999
-
Environmental contaminants and body fat distribution..
8:179-183.
1999
-
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status..
7:483-488.
1998
-
Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas..
7:553-555.
1998
-
Reduced DNA repair capacity in head and neck cancer patients..
7:465-468.
1998
-
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk..
7:371-378.
1998
-
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer..
7:309-314.
1998
-
Relationships among objective and subjective risk for breast cancer and mammography stages of change..
5:1005-1011.
1996
-
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia..
5:639-644.
1996
-
The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer..
5:329-335.
1996
-
Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection..
4:715-720.
1995
-
Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry..
3:597-605.
1994
-
Vitamin D and prostate cancer: a prediagnostic study with stored sera..
2:467-472.
1993
-
Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis..
2:329-333.
1993
-
Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients..
2:103-106.
1993
-
Identification of women at increased risk for breast cancer in a population-based screening program..
1:143-147.
1992
-
Abstract SS02-02: A long walk from FGFR2 alternative splicing to cancer progression.
23:SS02-02-SS02-02.
2014
-
Determinants of delays in care-seeking for ovarian cancer symptoms in African American women.
2018
-
Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.
2018
-
Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models
2018
-
Establishment of African American prostate cancer patient-derived primary cell lines and xenografts.
2018
-
Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells
2018
-
Abstract B44: Immune pathway dysregulations in inflammatory breast cancer health disparity
2017
-
Abstract B51: Dairy, calcium, vitamin D and ovarian cancer risk in African-American women
2017
-
Abstract A73: Obesity, weight gain, and ovarian cancer risk in African American women
2016
-
Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent
2016
-
Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families
2016
-
Abstract IA09: Intervening on the financial toxicity of cancer care
2016
-
Abstract PR05: Dietary quality and ovarian cancer risk in African American women
2016
-
Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer
2013
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
2005
-
Results from project LEAD (Leading the way in Exercise And Diet): A lifestyle intervention trial aimed at older adults diagnosed with breast and prostate cancer.
2005
-
Supplemental vitamin E increases biomarkers of estrogen stimulation in random core breast biopsies of women taking tamoxifen
2005
-
Childhood cancer survivors: Health behaviors and receptivity to health promotion interventions.
2004
-
Screening for therapy-related second cancers.
2004
-
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
2004
-
Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer.
2003
-
Imsulin-like growth factor-1 (IGF-1): An exploration of serum levels, binding protein (IGFBP-3) and IGF-1 CA repeat genotype, and the risk of prostae cancer
2003
-
A case-control study of candidate ovarian cancer susceptibility polymorphisms.
2002
-
Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia.
2002
-
Evaluation of ovarian cancer preventive agents in the chicken.
2002
-
Randomized controlled clinical trial of weekly oltipraz in smokers.
2002